Steven Hoerter

Steven L.
Hoerter is currently Chairman, President & Chief Executive Officer at MBX Biosciences, Inc. starting in 2026.
He is an Independent Director at Oric Pharmaceuticals, Inc. since 2021, at C4 Therapeutics, Inc. since 2024, and at Yarrow Bioscience, Inc. starting in 2026.
Formerly, Mr. Hoerter was President, Chief Executive Officer & Director at Deciphera Pharmaceuticals, Inc. from 2019 to 2024 and held a similar role at Deciphera Pharmaceuticals LLC.
He was Director-Pipeline Development at Genentech, Inc. from 2005 to 2010.
He served as Independent Director at Constellation Pharmaceuticals, Inc. from 2016 to 2018 and again from 2018 to 2021.
He was Independent Director at Ignyta, Inc. from 2016 to 2018.
He was Chief Commercial Officer at Agios Pharmaceuticals, Inc. from 2016 to 2019.
He held the position of GM, Head-Sub-Saharan Africa & Indian Ocean Region at Roche Group.
He was Chief Commercial Officer & Executive VP at Clovis Oncology, Inc. from 2015 to 2016.
Education includes an MBA from the University of Tilburg, undergraduate studies at Bucknell University, and graduate studies at the Krannert School of Management.